Related Experiment Video
Updated: May 12, 2026
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy?
Vinicius Kannen1, Sergio Britto Garcia, Helga Stopper
1Department of Toxicology, University of Wuerzburg, Germany. vinicius.cardoso@uni-wuerzburg.de
Abstract:
The role of glucagon-like peptide 2 (GLP2) in colon tissue has been studied extensively, from the time it was discovered that GLP2 promotes intestinal growth. A large number of studies have shown potential applications for GLP2 in human therapy. However, recent data have suggested the notion that GLP2 plays a key role in colon carcinogenesis. Questions have been arisen regarding the pro-proliferative effects of GLP2 and whether they might promote intestinal healing or advance colon tumor growth. Here, we provide striking evidence to show that the physiological activities of GLP2 are closely related to cancer-related molecular pathways that have been shown to circumvent drug desensitization. We further explore the different pathways of GLP2-signaling to suggest suitable GLP2-based therapeutic strategies in colon cancer.
Insights
Glucagon-like peptide 2 (GLP2) promotes intestinal growth but may also drive colon cancer progression. This study reveals GLP2’s link to cancer pathways, suggesting new therapeutic strategies for colon cancer.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Glucagon-like peptide 2 (GLP2) is known to promote intestinal growth.
- GLP2 has shown potential therapeutic applications in human medicine.
- Emerging evidence suggests GLP2 may play a role in colon carcinogenesis.
Purpose of the Study:
- To investigate the dual role of GLP2 in intestinal healing versus colon tumor growth.
- To explore the relationship between GLP2 physiological activities and cancer-related molecular pathways.
- To propose GLP2-based therapeutic strategies for colon cancer.
Main Methods:
- Analysis of GLP2 signaling pathways.
- Investigation of GLP2's role in cancer-related molecular pathways.
- Evaluation of GLP2's impact on cell proliferation and drug desensitization.
Main Results:
- GLP2's physiological activities are closely linked to cancer-related molecular pathways.
- These pathways can circumvent drug desensitization.
- Evidence suggests GLP2 may advance colon tumor growth.
Conclusions:
- GLP2's role in colon carcinogenesis requires careful consideration.
- Understanding GLP2-signaling pathways is crucial for developing effective colon cancer therapies.
- Targeting GLP2 pathways may offer novel therapeutic strategies for colon cancer.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
06:24Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
Related Concept Videos
01:24Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
02:38Mitogens and the Cell Cycle
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...